Andrew Bellinger - Net Worth and Insider Trading
Andrew Bellinger Net Worth
The estimated net worth of Andrew Bellinger is at least $42,624 dollars as of 2024-11-13. Andrew Bellinger is the CSO & CMO of Verve Therapeutics Inc and owns about 6,629 shares of Verve Therapeutics Inc (VERV) stock worth over $42,624. Details can be seen in Andrew Bellinger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Bellinger has not made any transactions after 2022-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Bellinger
Andrew Bellinger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Bellinger owns 1 companies in total, including Verve Therapeutics Inc (VERV) .
Click here to see the complete history of Andrew Bellinger’s form 4 insider trades.
Insider Ownership Summary of Andrew Bellinger
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VERV | Verve Therapeutics Inc | 2022-12-01 | Chief Scientific Officer |
Andrew Bellinger Latest Holdings Summary
Andrew Bellinger currently owns a total of 1 stock. Andrew Bellinger owns 6,629 shares of Verve Therapeutics Inc (VERV) as of December 1, 2022, with a value of $42,624.
Latest Holdings of Andrew Bellinger
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
VERV | Verve Therapeutics Inc | 2022-12-01 | 6,629 | 6.43 | 42,624 |
Holding Weightings of Andrew Bellinger
Andrew Bellinger Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Bellinger has made a total of 6 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Verve Therapeutics Inc is the sale of 865 shares on December 1, 2022, which brought Andrew Bellinger around $19,852.
Insider Trading History of Andrew Bellinger
- 1
Andrew Bellinger Trading Performance
Andrew Bellinger Ownership Network
Ownership Network List of Andrew Bellinger
Ownership Network Relation of Andrew Bellinger
Andrew Bellinger Owned Company Details
What does Verve Therapeutics Inc do?
Who are the key executives at Verve Therapeutics Inc?
Andrew Bellinger is the Chief Scientific Officer of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include See Remarks Andrew D. Ashe , Chief Administrative Officer Joan Nickerson , and director & 10 percent owner Krishna Yeshwant .
Verve Therapeutics Inc (VERV) Insider Trades Summary
Over the past 18 months, Andrew Bellinger made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .
In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.
Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verve Therapeutics Inc Insider Transactions
Andrew Bellinger Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Bellinger. You might contact Andrew Bellinger via mailing address: 500 Technology Square, Cambridge Ma 02139.